Adolescents' Non-suicidal Behavior and Perception of Parents' Negative Emotional Expression and Family Communication
Launched by SUN YAT-SEN UNIVERSITY · Feb 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the relationship between non-suicidal self-injury behaviors in adolescents and the way their parents express negative emotions and communicate within the family. Researchers want to see if there is a connection between how family members talk to each other and whether teenagers aged 15 to 25 engage in self-injury without the intention of suicide. To gather information, they will ask participants to fill out questionnaires, with a goal of including 327 young people in the study.
To be eligible for the trial, participants must fall within the 15-25 age range. There are three groups: one group includes teens who have been diagnosed with non-suicidal self-injury, another group includes teens who do not have this diagnosis but are receiving psychiatric care, and the third group consists of healthy teens with no mental health issues. Participants can expect to contribute to important research that may help improve family communication and support for adolescents facing emotional challenges. This study is not yet recruiting participants, but it aims to shed light on how family dynamics might influence the well-being of young people.
Gender
ALL
Eligibility criteria
- 1.Case group: NSSI patient group:
- Inclusion Criteria:
- • 1. Patients who meet the diagnostic criteria in DSM-5 and are clinically diagnosed as NSSI;
- • 2. Age range: 15-25 years old;
- • 3. Clear consciousness, normal speech function, able to communicate in Chinese and reading chinese;
- Exclusion Criteria:
- • 1. Users with organic diseases and psychoactive substances;
- • 2. NSSI; caused by autism, TIC disorder, mental retardation and other emotional instability and bad mood;
- • 3. Religious self-injury or customary self-injury;
- • 4. Patients with schizophrenia, schizoaffective disorder, alcohol dependence, organic mental disorder and other mental disorders have been previously diagnosed.
- • 2.Control group 1: Non-NSSI patients
- Inclusion criteria:
- • 1. Psychiatric outpatients or inpatients can read and understand the contents of the questionnaire;
- • 2. Patients who do not meet the diagnostic criteria in DSM-5 and are clinically diagnosed as NSSI.
- • 3. Age range: 15-25 years old;
- • 4. Patients and/or guardians can give informed consent and participate in this study.
- Exclusion criteria:
- • 1. Patients whose illness causes them unable to communicate or fill out questionnaires;
- • 2. Non-serious mental diseases, such as schizophrenia and schizoaffective disorder.
- • 3.Control group 2: Healthy group
- • Inclusion criteria
- • 1. No mental illness;
- • 2. Age range: 15-25 years old;
- • 3. Clear consciousness, normal speech function, able to communicate in Chinese and reading chinese;
- • 4. Patients and/or guardians can give informed consent and participate in this study.
- • Exclusion criteria
- • (1) Young people and adolescents who are unable to communicate or fill out questionnaires due to various organic reasons.
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Wei Xia, PhD
Principal Investigator
Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported